Eight Roads Ventures — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.
BiotechDigital HealthMedical DevicesSan Diego, US
Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)Vikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)
Co-investorsForesite CapitalLongwood FundNorwest Venture PartnersRiverVest Venture PartnersYsios Capitalabrdn plc+4 more
Laurus Bio, a subsidiary of Laurus Labs, is a biomanufacturing company using precision fermentation and recombinant DNA technology to produce animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements.
BiotechDeep TechFoodTechNew MaterialsBengaluru, IN
Rajesh Krishnamurthy(Executive Director & CEO)inKrishna Kalyan(Executive Director & COO)in
BoardDr. Satyanarayana Chava(Chairman)
Co-investorsF-Prime Capital
Shadowfax operates a logistics and delivery network in India, using a crowdsourced fleet of trucks, delivery partners, and agents to provide same-day and next-day courier and delivery services.
AI & Machine LearningE-commerceLogistics & Supply Chain
Abhishek Bansal(Founder)inPraharsh Chandra(Founder)in
Co-investorsIndigoEdgeNewBuild.VCNGP CapitalQualcomm VenturesTitan CapitalTrifecta Capital Advisors+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.